» Articles » PMID: 16286177

Functional Status in Rate- Versus Rhythm-control Strategies for Atrial Fibrillation: Results of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Functional Status Substudy

Overview
Date 2005 Nov 16
PMID 16286177
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) functional status substudy aimed to test the hypothesis that functional status is similar in rate-control and rhythm-control strategies.

Background: Randomized studies, including the AFFIRM study, have failed to demonstrate survival benefits between rate-control and rhythm-control strategies for atrial fibrillation (AF). However, AF may cause functional capacity or cognitive impairment that might justify maintenance of sinus rhythm.

Methods: Investigators of the AFFIRM study enrolled 4,060 patients with AF who required long-term therapy and who were 65 years of age or older or who had another risk factor for stroke or death. New York Heart Association functional class (NYHA-FC) and Canadian Cardiovascular Society Angina Classification were assessed at initial and each follow-up visit. From 22 randomly chosen functional status substudy sites, 245 participants underwent 6-min walk tests and Mini-Mental State Examination (MMSE) at initial, two-month, and yearly visits. Patients were assigned randomly to rate-controlling drugs, allowing AF to persist, or rhythm-controlling antiarrhythmic drugs, to maintain sinus rhythm.

Results: The NYHA-FC worsened with time in both rate-control and rhythm-control groups, with no differences between groups. Presence of AF was associated with worse NYHA-FC (p < 0.0001). No differences were observed in Canadian Cardiovascular Society Angina Classification or MMSE scores. Six-minute walk distance improved over time in both study arms. On average, walk distance was 94 feet greater in the rhythm-control group (adjusted p = 0.049).

Conclusions: Modest improvement in 6-min walk distance was noted in the rhythm-control arm. Presence of AF was associated with worse NYHA-FC. No difference in cognitive function was detected.

Citing Articles

Atrial High-Rate Episodes and Subclinical Atrial Fibrillation: State of the Art and Clinical Questions with Complex Solutions.

Griffith Brookles C, De Ponti R, Russo V, Ziacchi M, Pelargonio G, Casella M Rev Cardiovasc Med. 2024; 25(8):305.

PMID: 39228483 PMC: 11366991. DOI: 10.31083/j.rcm2508305.


Could the Early Detection of Atrial Fibrillation Reduce the Risk of Developing Dementia?.

Demoniere F, Abdelli R, Rivard L Biomedicines. 2024; 12(8).

PMID: 39200396 PMC: 11351480. DOI: 10.3390/biomedicines12081931.


Cognitive impairment and treatment strategy for atrial fibrillation in older adults: The SAGE-AF study.

Athreya D, Saczynski J, Gurwitz J, Monahan K, Bamgbade B, Paul T J Am Geriatr Soc. 2024; 72(7):2082-2090.

PMID: 38742376 PMC: 11610796. DOI: 10.1111/jgs.18949.


Is catheter ablation associated with preservation of cognitive function? An analysis from the SAGE-AF observational cohort study.

Srichawla B, Hamel A, Cook P, Aleyadeh R, Lessard D, Otabil E Front Neurol. 2024; 14:1302020.

PMID: 38249728 PMC: 10799336. DOI: 10.3389/fneur.2023.1302020.


The Impact of Atrial Fibrillation Treatment Strategies on Cognitive Function.

Bodagh N, Kotadia I, Gharaviri A, Zelaya F, Birns J, Bhalla A J Clin Med. 2023; 12(9).

PMID: 37176490 PMC: 10179566. DOI: 10.3390/jcm12093050.